Prospective study to identify predictive sensitivity of neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT)

Prospective study to identify predictive sensitivity of neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT) - Prospective study to identify predictive sensitivity of neoadjuvant chemoradiotherapy for rectal Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003398

Enrollment

Registered

2010-03-29

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer (Ra, Rb, P) diagnosed as adenocarcinoma and preoperatively diagnosed T3/4 , N0-3.

Interventions

neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rectal cancer (Ra, Rb, P) diagnosed as adenocarcinoma and T3/4, N0-3 preoperatively.

Exclusion criteria

Exclusion criteria: Cases that have crital drug sensitivity to TS-1 or multiple cacners, multiple colorectal cancers with activity.

Design outcomes

Primary

Measure	Time frame
To identify predictive sensitivity of locally advanced rectal cancer to preoperative chemoradiiotherapy	—

Countries

Japan

Contacts

Public ContactMasafumi Inomata

Oita University Faculty of Medicine Department of Surgery I

geka1@oita-u.ac.jp097-586-5843

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026